Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention
Authors:
Open Access
- 11 September 2018
- journal article
- review article
- Published by Wiley in Respirology
- Vol. 23 (11) , 1006-1022
Abstract
Interest in bronchiectasis has increased over the past two decades, as shown by the establishment of disease‐specific registries in several countries, the publication of management guidelines and a growing number of clinical trials to address evidence gaps for treatment decisions. This review considers the evidence for defining and treating pulmonary exacerbations, the approaches for eradication of newly identified airway pathogens and the methods to prevent exacerbations through long‐term treatments from a pragmatic practice‐based perspective. Areas for future studies are also explored.Watch the video abstractKeywords
Funding Information
- Department of Health, Queensland
- Innovative Medicines Initiative
- Medical Research Council Canada
- National Health and Medical Research Council (Project grant (633235))
- University of Kentucky
This publication has 122 references indexed in Scilit:
- Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trialTrials, 2013
- Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised studyEuropean Respiratory Journal, 2012
- Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infectionJournal of Clinical Investigation, 2011
- Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumoniaEuropean Respiratory Journal, 2011
- Respiratory Bacterial Pathogens in the Nasopharynx and Lower Airways of Australian Indigenous Children with BronchiectasisThe Journal of Pediatrics, 2010
- Immunomodulatory Effects of Macrolide Antibiotics – Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide TherapyRespiration, 2010
- Do New Zealand children with non‐cystic fibrosis bronchiectasis show disease progression?Pediatric Pulmonology, 2010
- British Thoracic Society guideline for non-CFbronchiectasisThorax, 2010
- Bronchiectasis secondary to primary immunodeficiency in children: Longitudinal changes in structure and functionPediatric Pulmonology, 2009
- Treatment of paediatric non-cystic fibrosis bronchiectasisExpert Opinion on Pharmacotherapy, 2004